Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.

Featured Stories

ERISA Recap: 6 Important Rulings From July No Photo Available

The Ninth Circuit rejected a fund manager's bid to force a 401(k) suit into arbitration, a district court tossed a pension de-risking ... (more story)

This Week's Healthcare Earnings: Pfizer, Cigna And More No Photo Available

Major companies across the pharmaceutical and insurance industries posted their second quarter results this past week. Law360 looks at... (more story)

HHS Disclosures, Trans Care Bar Targeted In New Suits No Photo Available

Law360 Healthcare Authority looks at new suits filed over the past week, including challenges to the U.S. Department of Health and Hum... (more story)